医学中的真正透明化：是时候采取行动了。
Real transparency in medicine: Time to act.
机构信息
American Society of Clinical Oncology, Alexandria, Virginia.
National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania.
出版信息
Cancer. 2019 Nov 15;125(22):3924-3926. doi: 10.1002/cncr.32407. Epub 2019 Jul 29.
Abstract
Current methods of recording and reporting financial conflicts of interest are flawed and often result in inaccurate and inconsistent reporting by well‐intentioned individuals. To that end, this editorial identifies a number of specific current challenges for conflict‐of‐interest reporting along with potential solutions.
摘要
当前记录和报告财务利益冲突的方法存在缺陷，往往导致善意个人的报告不准确且不一致。为此，本社论确定了利益冲突报告当前面临的一些具体挑战以及潜在的解决方案。
相似文献
1
Real transparency in medicine: Time to act.医学中的真正透明化：是时候采取行动了。
Cancer. 2019 Nov 15;125(22):3924-3926. doi: 10.1002/cncr.32407. Epub 2019 Jul 29.
2
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.美国临床肿瘤学会临床实践指南作者的未披露财务利益冲突。
Cancer. 2019 Nov 15;125(22):4069-4075. doi: 10.1002/cncr.32408. Epub 2019 Jul 29.
3
An Evaluation of Industry Relationships Among Contributors to AAOS Clinical Practice Guidelines and Appropriate Use Criteria.一项对 AAOS 临床实践指南和适当使用标准制定者的行业关系的评估。
J Bone Joint Surg Am. 2018 Jan 17;100(2):e10. doi: 10.2106/JBJS.17.00184.
4
Financial Conflicts of Interest Among Authors of Endocrine Society Clinical Practice Guidelines.内分泌学会临床实践指南作者的财务利益冲突。
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4333-4338. doi: 10.1210/jc.2018-00526.
5
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.评价日本肿瘤临床实践指南作者的制药公司支付情况和利益冲突披露
JAMA Netw Open. 2019 Apr 5;2(4):e192834. doi: 10.1001/jamanetworkopen.2019.2834.
6
Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors.评估皮肤科临床实践指南作者的行业报酬。
JAMA Dermatol. 2017 Dec 1;153(12):1229-1235. doi: 10.1001/jamadermatol.2017.3109.
7
Conflict of Interest Disclosure in a Top-Tier Portuguese Medical Journal.葡萄牙顶级医学期刊中的利益冲突披露
Acta Med Port. 2017 Sep 29;30(9):652-655. doi: 10.20344/amp.8458.
8
(Re)disclosing physician financial interests: rebuilding trust or making unreasonable burdens on physicians?（重新）披露医生的经济利益：重建信任还是给医生带来不合理负担？
Med Health Care Philos. 2017 Jun;20(2):179-186. doi: 10.1007/s11019-017-9751-8.
9
Shadows amid sunshine: regulating financial conflicts in medical research.阳光中的阴影：规范医学研究中的财务冲突。
Chest. 2014 Feb;145(2):379-385. doi: 10.1378/chest.13-1719.
10
Financial Conflicts of Interest Among Emergency Medicine Journals' Editorial Boards.急诊医学期刊编委会的财务利益冲突。
Ann Emerg Med. 2020 Mar;75(3):418-422. doi: 10.1016/j.annemergmed.2019.02.020. Epub 2019 Apr 5.
引用本文的文献
1
Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy.国家综合癌症网络利益冲突财务政策的执行趋势。
JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae120.
本文引用的文献
1
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.美国临床肿瘤学会临床实践指南作者的未披露财务利益冲突。
Cancer. 2019 Nov 15;125(22):4069-4075. doi: 10.1002/cncr.32408. Epub 2019 Jul 29.
2
Prevalence of Financial Conflicts of Interest Among Authors of Clinical Guidelines Related to High-Revenue Medications.高收益药物相关临床指南作者的财务利益冲突发生率。
JAMA Intern Med. 2018 Dec 1;178(12):1712-1715. doi: 10.1001/jamainternmed.2018.5106.
3
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors.国家综合癌症网络指南作者与行业的财务关系。
JAMA Oncol. 2016 Dec 1;2(12):1628-1631. doi: 10.1001/jamaoncol.2016.2710.
4
Dealing with conflicts of interest.处理利益冲突。
N Engl J Med. 1984 May 3;310(18):1182-3. doi: 10.1056/NEJM198405033101809.
Zotero 插件